How many studies have been conducted on Trimethaphan?

BiohacksAI has indexed 300 PubMed studies on Trimethaphan, including 14 randomized controlled trials (RCTs). 36% of studies involve human subjects.

What are the main research areas for Trimethaphan?

The primary research domains for Trimethaphan are ❤️ Cardiovascular, 🧠 Focus & Attention, 🫘 Kidney. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Trimethaphan

A nicotinic antagonist that has been used as a ganglionic blocker in hypertension, as an adjunct to anesthesia, and to induce hypotension during surgery.

300+ PubMed studies analyzed · 14 RCTs · Evidence Score: 48.7

Research Domains

Trimethaphan has been studied across 20 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 🫘 Kidney, 🔥 Metabolic, 😴 Sleep. The primary research focus is ❤️ Cardiovascular with 50% of studies addressing this area.

Loading evidence profile...

This evidence profile for Trimethaphan is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.